Skip to Content

M 702 (Rizatriptan Benzoate (Orally Disintegrating) 10 mg (base))

Pill with imprint M 702 is White, Round and has been identified as Rizatriptan Benzoate (Orally Disintegrating) 10 mg (base). It is supplied by Mylan Pharmaceuticals Inc..

Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 10 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 702

Rizatriptan benzoate (orally disintegrating) 10 mg (base) M 702 Front
Rizatriptan benzoate (orally disintegrating) 10 mg (base) M 702 Back

Rizatriptan Benzoate (Orally Disintegrating)

Imprint
M 702
Strength
10 mg (base)
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Antimigraine agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-3702

Get help with Imprint Code FAQs.

Related Images for "M 702"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.